News from IVAC

November 2020

IVAC REPORT TRACKS GLOBAL GAINS MADE TO REDUCE BURDEN OF CHILD PNEUMONIA AND DIARRHEA DEATHS

Released ahead of World Pneumonia Day, November 12, the latest annual Pneumonia and Diarrhea Progress Report from the International Vaccine Access Center (IVAC) shows some bright spots in preventing child pneumonia and diarrhea deaths, but service disruptions due to COVID-19 may threaten decades of progress in reducing global child mortality. Pneumonia and diarrhea kill more […]

Read More >
October 2020

Watch World Pneumonia Day Panel Discussion (Nov 2020)

Pneumonia claims the lives of more young children than any other disease – over 800,000 children under 5 each year worldwide are lost to this largely preventable infectious disease. The COVID-19 pandemic now threatens global progress on preventing and treating childhood pneumonia, potentially reversing decades of health gains for the world’s most vulnerable children. A […]

Read More >
October 2020

IVAC Support for SAGE October 2020 Meeting

WHO’s Strategic Advisory Group of Experts (SAGE) on Immunizations met October 5-7, 2020 to discuss topics including the use of pneumococcal vaccines in older adults, expanded recommendations on rotavirus vaccines, the impact of the pandemic on immunization, and the Immunization Agenda 2030. IVAC regularly participates in semiannual SAGE meetings, providing research summaries and other assistance to […]

Read More >
August 2020

Webinar Recording: Avoiding Barriers to Access for a COVID-19 Vaccine

The International Vaccine Access Center (IVAC) hosted a webinar on September 16th, “Avoiding Barriers to Access for a COVID-19 Vaccine.” Description: Even before the COVID-19 pandemic, countries worked to overcome a myriad of challenges when introducing new safe and effective vaccines. While policy makers and health advocates addressed barriers, from understanding disease burden and cost […]

Read More >
August 2020

Visualizing Vaccines

By Graphicacy Originally published on Medium OVERVIEW In 2016, the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health introduced its revolutionary online platform, VIEW-hub, as a one-stop resource for global vaccine data. This interactive, map-based platform allowed researchers, policymakers, public health officials, and program funders to call up data […]

Read More >
August 2020

DoVE Return on Investment (ROI) Publication Launch

The Decade of Vaccine Economics (DoVE) Project, carried out by the Johns Hopkins Bloomberg School of Public Health’s International Vaccine Access Center (IVAC) for nearly ten years, has computed the return-on-investment for vaccines preventing 10 infectious diseases in 73 countries that have received support from Gavi, the Vaccine Alliance.

Read More >
July 2020

Joint Statement on COVID-19 Vaccines & Older Adults

As WHO, CEPI, and Gavi meet and consider how best to manage the planning and deployment of a COVID-19 vaccine, we feel the voice of older adults, one of the most vulnerable, important, and essential groups should feature prominently in the COVAX process. In keeping with COVAX’s stated goal of equity, we recommend: Prioritizing development […]

Read More >